Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tissue-specific hemostasis in mice.

Nigel Mackman1

  • 1Department of Immunology, Scripps Research Institute, La Jolla, CA 92037, USA. nmackman@scripps.edu

Arteriosclerosis, Thrombosis, and Vascular Biology
|August 27, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A novel G13-RAPGEF2-RAP1 signaling pathway critical for platelet adhesion and aggregation.

Blood·2026
Same author

Evaluation of 3 commercial assays for the measurement of tissue factor activity in human plasma.

Research and practice in thrombosis and haemostasis·2026
Same author

Tissue factor detection in mouse tissues by western blotting using commercial antibodies.

Research and practice in thrombosis and haemostasis·2026
Same author

Comparison of changes in blood cells and hemostatic biomarkers in mouse xenograft models of acute myeloid leukemia and acute promyelocytic leukemia.

Research and practice in thrombosis and haemostasis·2026
Same author

Potential Mechanisms Underlying Bleeding During Infection With Hemorrhagic Fever Viruses.

Arteriosclerosis, thrombosis, and vascular biology·2025
Same author

New light on the activators of factor XI in venous thromboembolism.

Lancet (London, England)·2025
Same journal

Exploring the Role of Hypusine Signaling in Vascular Smooth Muscle Cells for Mitigating Restenosis in Coronary Artery Disease.

Arteriosclerosis, thrombosis, and vascular biology·2026
Same journal

Circulating Extracellular Mitochondria Perpetuate Endothelial Damage via Cardiolipin-Mediated Mitophagic Overload.

Arteriosclerosis, thrombosis, and vascular biology·2026
Same journal

Myeloid Cell-Specific Deletion of LGR4 Suppresses Atherosclerotic Lesion Formation.

Arteriosclerosis, thrombosis, and vascular biology·2026
Same journal

Building Resilience in Academic Science and Medicine.

Arteriosclerosis, thrombosis, and vascular biology·2026
Same journal

Endothelial Continuum and Capillary Specialization in Pulmonary Vascular Development.

Arteriosclerosis, thrombosis, and vascular biology·2026
Same journal

Systematic Review and Meta-Analysis Examining the Effect of Upregulation and Inhibition of Proprotein Convertase Subtilisin/Kexin Type 9 in Mouse Models of Abdominal Aortic Aneurysm.

Arteriosclerosis, thrombosis, and vascular biology·2026
See all related articles

Blood coagulation and fibrinolysis are tightly regulated processes essential for hemostasis. This study reveals that hemostasis is controlled in a tissue-specific manner, impacting clot formation and removal.

Area of Science:

  • Biochemistry
  • Physiology
  • Molecular Biology

Background:

  • Blood coagulation is vital for hemostasis, involving a protease cascade to form fibrin clots at injury sites.
  • Anticoagulant pathways and the fibrinolytic system regulate clot formation and removal, preventing hemorrhage or thrombosis.
  • Tissue factor initiates coagulation, while tissue factor pathway inhibitor, antithrombin, and protein C are key anticoagulants.

Purpose of the Study:

  • To investigate the tissue-specific regulation of hemostasis.
  • To understand the roles of procoagulant, anticoagulant, and fibrinolytic pathways in different tissues.
  • To elucidate how tissue-specific expression of regulatory molecules impacts hemostasis.

Main Methods:

  • Analysis of gene and protein expression patterns for coagulation factors and regulators.

Related Experiment Videos

  • Examination of knockout mouse models with defects in hemostasis pathways.
  • In vivo and in vitro studies to assess clot formation, anticoagulation, and fibrinolysis in specific tissues.

    • Main Results:

    • Tissue factor expression is tissue-specific, initiating coagulation.
    • Anticoagulant proteins (tissue factor pathway inhibitor, thrombomodulin, antithrombin, protein C) exhibit distinct tissue-specific expression patterns.
    • Fibrinolytic activators (tissue-type plasminogen activator) also show tissue-specific localization.
    • Mouse models with pathway defects confirm tissue-specific regulation of hemostasis.

    Conclusions:

    • Hemostasis is a highly regulated process with significant tissue-specific control.
    • The localized expression of procoagulant, anticoagulant, and fibrinolytic components ensures precise regulation of clot formation and breakdown.
    • Understanding tissue-specific hemostasis is crucial for developing targeted therapies for bleeding and clotting disorders.